A Randomised, Double Blind, Placebo-Controlled Pilot Study of Oral Artesunate Therapy for Colorectal CancerPhase 1 Trials of rVSV Ebola Vaccine in Africa and EuropeClindamycin as an antimalarial drug: review of clinical trials.Fosmidomycin plus clindamycin for treatment of pediatric patients aged 1 to 14 years with Plasmodium falciparum malariaAnalysis of IgG with specificity for variant surface antigens expressed by placental Plasmodium falciparum isolatesSevere falciparum malaria in Gabonese children: clinical and laboratory featuresAssessment of volume depletion in children with malariaThe Influence of Sub-Unit Composition and Expression System on the Functional Antibody Response in the Development of a VAR2CSA Based Plasmodium falciparum Placental Malaria VaccineCharacterisation of a tryptophan-rich Plasmodium falciparum antigen associated with merozoitesRestricted polymorphisms of the mannose-binding lectin gene in a population of Papua New GuineaPlasmodium induces swelling-activated ClC-2 anion channels in the host erythrocyteGenetic conservation of the GIL blood group determining aquaporin 3 gene in African and Caucasian populationsA phase 3 trial of RTS,S/AS01 malaria vaccine in African infantsPlasmodium falciparum activates endogenous Cl(-) channels of human erythrocytes by membrane oxidation.The cost-effectiveness of intermittent preventive treatment for malaria in infants in Sub-Saharan AfricaPaediatric pharmacovigilance: use of pharmacovigilance data mining algorithms for signal detection in a safety dataset of a paediatric clinical study conducted in seven African countriesIntermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-negative women: a multicentre randomized controlled trialEconomic evaluation of an alternative drug to sulfadoxine-pyrimethamine as intermittent preventive treatment of malaria in pregnancyMortality, Morbidity, and Developmental Outcomes in Infants Born to Women Who Received Either Mefloquine or Sulfadoxine-Pyrimethamine as Intermittent Preventive Treatment of Malaria in Pregnancy: A Cohort StudyIntramuscular Artesunate for Severe Malaria in African Children: A Multicenter Randomized Controlled TrialSchistosomes induce regulatory features in human and mouse CD1d(hi) B cells: inhibition of allergic inflammation by IL-10 and regulatory T cellsInduction of Plasmodium falciparum-specific CD4+ T cells and memory B cells in Gabonese children vaccinated with RTS,S/AS01(E) and RTS,S/AS02(D)Cellular and humoral responses to influenza in gabonese children living in rural and semi-urban areas.Molecular characterization of Shigella spp. from patients in Gabon 2011-2013.A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms.Population structure of Staphylococcus aureus from remote African Babongo PygmiesThe effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient dataShort report: Piloting paperless data entry for clinical research in Africa.Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trialStandardized data collection for multi-center clinical studies of severe malaria in African children: establishing the SMAC network.Inverse relationship of plasma prostaglandin E2 and blood mononuclear cell cyclooxygenase-2 with disease severity in children with Plasmodium falciparum malaria.Effect of antipyretic drugs in children with malaria.Declining chloroquine resistance of Plasmodium falciparum in Lambaréné, Gabon from 1992 to 1998.Full blood count and haemozoin-containing leukocytes in children with malaria: diagnostic value and association with disease severityA randomized trial assessing the safety and immunogenicity of AS01 and AS02 adjuvanted RTS,S malaria vaccine candidates in children in Gabon.Influenza in AfricaFunctional impairment of human myeloid dendritic cells during Schistosoma haematobium infection.Phylogenetic nomenclature and evolution of mannose-binding lectin (MBL2) haplotypes.Evidence of decline of malaria in the general hospital of Libreville, Gabon from 2000 to 2008Low interleukin-12 activity in severe Plasmodium falciparum malaria
P50
Q22061945-47CD2D90-15B4-484E-843F-92BFF4D1FFAAQ24289281-DE22C178-A17C-45AC-ADF9-2CABA7081601Q24536057-A4326117-F3E7-4D79-8DD8-424177553373Q24680404-284C3C59-BCC9-42CD-BBBF-170293C9235FQ24792921-BA9E723A-9DBB-429B-A557-C099EDF548E6Q24795463-F266C2FF-8B69-4A16-8C02-579939057985Q24802309-E0672871-EB6C-4417-9668-FAAEA377C100Q27300745-6E29767B-2EE0-46B0-BCDD-4D0CA4498211Q27972755-65C57684-371B-4CFE-BE3A-EC116DCCA668Q28217640-670C915A-F76B-45E0-B076-EA52C58BC439Q28273542-839B9D9B-6AA1-4416-BC5F-F77314CA47CAQ28277684-ED3F2ACA-3E14-4524-9C60-8139E8C1CFCFQ28278852-823575D5-70EB-419C-8AB0-488D9EB89FA4Q28344722-8F674DDF-9D82-4806-8245-33D39BEB6F49Q28474404-294DE680-CD45-42FD-B364-3A270B43FDB4Q28538338-34D94432-D0B0-4E89-8348-E035B7D1C5B9Q28543146-C965E58B-453F-4645-92A0-9E8194DEE460Q28546725-4D161FA8-E5E7-440F-B3A7-1CB8D6FAE994Q28550346-6FD1B241-D839-45A4-870D-90986763417EQ28552379-7E82A1E9-0946-432F-A9A9-05B9E26F4D68Q28732193-792C1ECA-2F17-4B9F-9A32-8789FF2639FDQ28741242-CAE0E4FA-FA22-4A62-8E66-2C93A233E841Q30365877-1F6207C5-AB74-49CE-B068-84B8C2006AB2Q30368857-4BD27B67-A765-44DB-9463-2ED0D3F3952FQ30379780-EAF12C0F-4426-49CC-A658-BB47A5E59B35Q30402690-9DAB2D47-7E52-4ED7-B394-674E07B63EEBQ30936416-D6BD40EF-8D21-42DB-A779-AD22BDC9DA01Q30985008-22E8616E-9E33-4C0B-B7B3-213A7F6DA59FQ30991737-EEC109B9-B69A-401D-B4FE-487DB9B3B83AQ31034787-BCF01E72-4316-40C3-8612-9549951708EBQ31558630-823A9204-ECC2-4124-91A6-8537BA4D5F59Q32068657-FA869A48-8A95-401C-88A0-543BE3430A0CQ32098036-E720EFD7-595B-4378-8E05-4E4BF9178394Q33343300-C6BBFE09-352E-4E6D-924E-3C588B786E8EQ33512921-0F1038C8-A930-45A8-8E2E-5DCF59BDD317Q33519030-2A875AC2-0EF2-489A-87CB-D2828234A5A1Q33565632-035022BF-B0C4-4569-83F3-EAA0B857BB92Q33577516-4B02085E-50DD-4E36-8AF7-1FC156B7A211Q33590182-225EAF6D-12E7-4956-8BC2-51EAD2C10EBFQ33596195-EE745B62-9EB2-4456-8235-D262DAFDF6F2
P50
description
Austria arst
@et
Austrian physician
@en
arts uit Oostenrijk
@nl
dochtúir Ostarach
@ga
medic austriac
@ro
metge austríac
@ca
mjek austriak
@sq
médecin chercheur autrichien
@fr
médico austríaco
@es
médico austríaco
@gl
name
Peter Gottfried Kremsner
@ast
Peter Gottfried Kremsner
@ca
Peter Gottfried Kremsner
@de
Peter Gottfried Kremsner
@en
Peter Gottfried Kremsner
@es
Peter Gottfried Kremsner
@fr
Peter Gottfried Kremsner
@ga
Peter Gottfried Kremsner
@nl
Peter Gottfried Kremsner
@sl
Peter Gottfried Kremsner
@sq
type
label
Peter Gottfried Kremsner
@ast
Peter Gottfried Kremsner
@ca
Peter Gottfried Kremsner
@de
Peter Gottfried Kremsner
@en
Peter Gottfried Kremsner
@es
Peter Gottfried Kremsner
@fr
Peter Gottfried Kremsner
@ga
Peter Gottfried Kremsner
@nl
Peter Gottfried Kremsner
@sl
Peter Gottfried Kremsner
@sq
altLabel
Kremsner P
@en
Kremsner P. G.
@en
Kremsner P.
@en
Kremsner PG
@en
Kremsner
@en
P G Kremsner
@en
P Kremsner
@en
P. G. Kremsner
@en
P. Kremsner
@en
Peter G Kremsner
@en
prefLabel
Peter Gottfried Kremsner
@ast
Peter Gottfried Kremsner
@ca
Peter Gottfried Kremsner
@de
Peter Gottfried Kremsner
@en
Peter Gottfried Kremsner
@es
Peter Gottfried Kremsner
@fr
Peter Gottfried Kremsner
@ga
Peter Gottfried Kremsner
@nl
Peter Gottfried Kremsner
@sl
Peter Gottfried Kremsner
@sq
P227
P106
P21
P214
5243155044874972520006
P227
1189129418
P27
P31
P569
1961-05-16T00:00:00Z
P735
P7859
viaf-5243155044874972520006